Hematology
Consultant – Haematology22+ years
Fortis Hospitals
Kolkata
Dr. Shuvra Neel Baul (Basu) is a Consultant in Haematology at Fortis Hospital Anandapur, Kolkata. The official Fortis Healthcare profile reports 19 years of professional experience. The doctor's practice focuses on clinical haematology, including the assessment and management of benign blood disorders, haematological malignancies and complex conditions affecting blood cells and bone marrow function.
Dr. Shuvra Neel Baul (Basu) holds an MBBS, MD in General Medicine and DM in Clinical Haematology. These qualifications provide a foundation in adult medicine and advanced specialist care for disorders involving red blood cells, white blood cells, platelets and the blood-forming system. The published professional history also describes experience in the diagnosis and management of complex haematological conditions.
Anaemia, thalassaemia and bleeding disorders are among the reported clinical interests. These conditions may result from nutritional deficiencies, inherited blood disorders, abnormal clotting mechanisms or bone marrow problems. Specialist evaluation can involve complete blood counts, peripheral blood examination, iron studies, haemoglobin analysis and selected investigations based on the patient's symptoms and clinical findings.
Dr. Baul also has documented interests in malignant blood disorders, including leukaemia, lymphoma and multiple myeloma. These diseases affect different types of blood-forming or immune cells and require accurate diagnosis and classification. Management may involve specialised laboratory tests, bone marrow examinations, imaging and coordination with haematology-oncology teams to plan appropriate treatment.
Myelodysplastic syndromes, aplastic anaemia and platelet disorders are additional areas listed in the supplementary professional profile. These conditions can affect the production or function of blood cells and may cause fatigue, infection risk, bruising or abnormal bleeding. Treatment depends on the underlying diagnosis, disease severity, age, coexisting conditions and individual clinical circumstances.
Bone marrow examination and bone marrow transplant evaluation are included among Dr. Shuvra Neel Baul (Basu)'s reported clinical services. Transplant-related care requires comprehensive assessment and coordination with an accredited specialist team. Patients seeking evaluation for abnormal blood counts, inherited blood disorders, blood cancers or bone marrow diseases can enquire through Fortis Hospital Anandapur, Kolkata, subject to current consultation and treatment availability.
Clinical haematology focuses on diagnosing and managing disorders affecting blood cells, bone marrow and blood clotting systems. Assessment may involve reviewing symptoms, blood count abnormalities, medical history and previous laboratory findings. Further investigations and treatment are selected according to the suspected condition and the patient's overall clinical circumstances.
Anaemia occurs when haemoglobin or red blood cell levels are insufficient to meet the body's needs. Symptoms may include tiredness, weakness, dizziness and breathlessness. Evaluation can involve blood counts, iron and vitamin studies and other targeted investigations. Treatment depends on the underlying cause rather than simply increasing haemoglobin levels.
Iron deficiency anaemia develops when the body lacks sufficient iron for normal red blood cell production. Causes may include blood loss, inadequate intake or reduced absorption. Assessment includes blood counts, ferritin and investigations for the underlying cause. Treatment may involve oral or intravenous iron when clinically appropriate.
Thalassaemia is a group of inherited blood conditions affecting haemoglobin production. The severity varies from mild carrier states to disorders requiring regular treatment. Evaluation includes blood counts, haemoglobin analysis and selected genetic investigations. Management may involve monitoring, transfusion support and specialist assessment for advanced treatment options.
Haemophilia and other bleeding disorders may affect the body's ability to form stable blood clots. Patients can experience prolonged bleeding, bruising or bleeding into joints and tissues. Evaluation involves clinical history and coagulation investigations. Treatment may include specific clotting factor therapies or other measures according to the diagnosis.
Thrombotic disorders are associated with abnormal blood clot formation that can obstruct circulation. Evaluation considers the location of the clot, symptoms, medical history and potential risk factors. Treatment may involve anticoagulation and investigation of contributing conditions. Sudden breathlessness, chest pain or significant leg swelling requires urgent medical assessment.
Platelet disorders may involve abnormally low or high platelet counts or impaired platelet function. Symptoms can include bruising, unusual bleeding or, in certain conditions, an increased clotting risk. Assessment involves reviewing blood counts, clinical history and selected tests. Treatment depends on the type of platelet abnormality and associated risks.
Leukaemia is a group of cancers affecting blood-forming cells, often involving abnormal white blood cell production. Symptoms may include fatigue, infections, bruising or other blood count abnormalities. Diagnosis can require blood tests, bone marrow examination and specialised molecular investigations. Treatment depends on the specific type and risk classification.
Lymphoma is a cancer involving cells of the lymphatic and immune systems. Possible symptoms include enlarged lymph nodes, fever, night sweats and unexplained weight loss. Diagnosis generally requires tissue assessment and appropriate staging investigations. Treatment depends on lymphoma subtype, disease extent and the patient's medical condition.
Multiple myeloma is a cancer affecting plasma cells in the bone marrow. It can cause anaemia, bone disease, kidney problems or abnormal blood protein levels. Evaluation may include blood and urine studies, imaging and bone marrow examination. Treatment is planned according to disease characteristics and individual health factors.
Myelodysplastic syndromes are bone marrow disorders in which blood cell production becomes abnormal or ineffective. Patients may develop anaemia, infection risk or bleeding problems. Diagnosis often requires bone marrow studies and specialised testing. Treatment depends on disease risk, symptoms and the patient's overall health.
Aplastic anaemia occurs when the bone marrow fails to produce sufficient blood cells. Patients may experience fatigue, infections or unusual bleeding. Diagnosis requires detailed blood testing and usually bone marrow examination. Management may involve supportive care, immunosuppressive treatment or consideration of stem cell transplantation in selected cases.
Bone marrow examination helps investigate unexplained blood cell abnormalities and certain blood cancers or marrow disorders. Samples may be obtained through aspiration or biopsy when indicated. The results are interpreted alongside blood tests, clinical findings and specialised investigations to establish a diagnosis and guide treatment planning.
Bone marrow or haematopoietic stem cell transplantation may be considered for selected blood cancers, inherited disorders and bone marrow failure conditions. Evaluation includes confirming the diagnosis, reviewing treatment history, assessing organ function and identifying suitable transplant options. Transplant procedures require a dedicated multidisciplinary transplant service.
Some blood disorders require transfusion of red blood cells, platelets or other blood components. The decision depends on symptoms, laboratory results, bleeding risk and the patient's clinical status. Repeated transfusions require careful monitoring for reactions, iron overload and other potential complications.
Haematological cancer care involves the evaluation of conditions such as leukaemia, lymphoma and multiple myeloma. Treatment planning may include medication, chemotherapy, targeted therapies, immunotherapy or stem cell transplant assessment when indicated. The appropriate approach depends on the confirmed diagnosis, molecular findings, disease stage and individual patient factors.
MBBS, MD (General Medicine), DM (Clinical Haematology)
Clinical Haematology Consultation, Anaemia Assessment, Iron Deficiency Anaemia, Thalassaemia Management, Haemophilia and Bleeding Disorders, Thrombotic Disorders, Platelet Disorder Evaluation, Leukaemia Consultation, Lymphoma Assessment, Multiple Myeloma Management, Myelodysplastic Syndrome, Aplastic Anaemia, Bone Marrow Examination, Bone Marrow Biopsy Assessment, Bone Marrow Transplant Evaluation, Blood Transfusion-Related Consultation and Haematological Cancer Treatment Planning.
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Shuvra Neel Baul (Basu)
Dr. Shuvra Neel Baul (Basu) is a Consultant Clinical Haematologist at Fortis Hospital Anandapur, Kolkata, specialising in benign and malignant blood disorders.
Fortis lists MBBS, MD (General Medicine) and DM (Clinical Haematology). HexaHealth additionally reports DNB (General Medicine), which requires confirmation.
Fortis reports 19 years, while Satyug reports 19+ years and HexaHealth 22+ years. The recommended provisional Medpas figure is 19 years.
Yes. Both conditions are explicitly listed among the doctor's clinical areas of expertise by Satyug Healthcare.
Leukaemia and lymphoma are included in the supplementary professional profile. Appropriate treatment depends on the exact disease subtype and specialist evaluation.
Contact us for personalized help or to schedule an appointment.